-+ 0.00%
-+ 0.00%
-+ 0.00%

LifeSci Capital Initiates Coverage On Upstream Bio with Outperform Rating, Announces Price Target of $43

Benzinga·12/02/2025 12:54:53
Listen to the news
LifeSci Capital initiates coverage on Upstream Bio (NASDAQ:UPB) with a Outperform rating and announces Price Target of $43.